LAGHI, Luigi Andrea Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.295
EU - Europa 2.281
AS - Asia 1.392
SA - Sud America 379
AF - Africa 33
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.385
Nazione #
US - Stati Uniti d'America 3.261
SG - Singapore 1.035
IE - Irlanda 775
SE - Svezia 616
BR - Brasile 355
IT - Italia 261
NL - Olanda 209
CN - Cina 172
FI - Finlandia 136
DE - Germania 89
HK - Hong Kong 75
AT - Austria 34
RU - Federazione Russa 33
BE - Belgio 26
TR - Turchia 24
UA - Ucraina 24
GB - Regno Unito 23
CA - Canada 22
FR - Francia 21
IN - India 17
BD - Bangladesh 15
CI - Costa d'Avorio 13
IR - Iran 8
MX - Messico 8
PE - Perù 7
AR - Argentina 6
MA - Marocco 6
PL - Polonia 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
JP - Giappone 5
LT - Lituania 5
AZ - Azerbaigian 4
DK - Danimarca 4
EC - Ecuador 4
ID - Indonesia 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
KE - Kenya 3
PY - Paraguay 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PK - Pakistan 2
RO - Romania 2
AO - Angola 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ES - Italia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
VN - Vietnam 1
Totale 7.385
Città #
Dublin 763
Chandler 723
Singapore 636
Santa Clara 466
Ashburn 293
Boardman 194
Princeton 167
Helsinki 131
Des Moines 100
Hong Kong 75
Ann Arbor 72
Wilmington 61
Shanghai 51
Beijing 48
The Dalles 35
Seattle 30
New York 28
Bremen 25
Council Bluffs 25
Parma 25
Moscow 24
Nuremberg 23
São Paulo 23
Vienna 23
Los Angeles 22
Milan 21
Kocaeli 19
Brussels 17
Dallas 17
Soragna 17
Modena 15
Fidenza 14
Abidjan 13
Augusta 13
Bologna 12
Houston 11
Toronto 10
Woodbridge 10
Columbus 9
Fairfield 9
Ath 8
Belo Horizonte 8
Brasília 8
Rockville 8
Norwalk 7
Arezzo 6
Borås 6
Campinas 6
Ferrara 6
Lima 6
Mumbai 6
Rome 6
Tashkent 6
Catania 5
Guarulhos 5
Leawood 5
Munich 5
San Mateo 5
Turku 5
Warsaw 5
Baku 4
London 4
Monmouth Junction 4
Ottawa 4
Phoenix 4
Porto Alegre 4
Rimini 4
Rio de Janeiro 4
San Francisco 4
Santo André 4
Traversetolo 4
Trento 4
Wuhan 4
Amsterdam 3
Ardabil 3
Betim 3
Brooklyn 3
Charlotte 3
Cotia 3
Edinburgh 3
Falls Church 3
Fortaleza 3
Frankfurt am Main 3
Grafing 3
Guangzhou 3
Jakarta 3
Joinville 3
Nairobi 3
Patos 3
Piracicaba 3
Prague 3
Salvador 3
Silkeborg 3
Viamão 3
Aikawa 2
Anápolis 2
Aracaju 2
Auckland 2
Baghdad 2
Barbacena 2
Totale 4.519
Nome #
Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality 110
PEG reimplantation after Buried Bumper Syndrome: a case report 109
Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinoma 78
Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer 74
Alternatively spliced fibronectin extra domain a is required for hemangiogenic recovery upon bone marrow chemotherapy 70
CD3+cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study 69
Combined low densities of FOXP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 68
Amplification of JC virus (JCV) sequences from human colorectal cancers. 67
K-RAS2 CODON-12 GAT AND GTT COEXISTING SSCPS OCCUR FREQUENTLY IN PERIAMPULLARY NEOPLASMS OF PANCREATIC AS WELL AS OF BILIARY ORIGIN 67
Fusobacterium nucleatum and the Immune System in Colorectal Cancer 66
CD3+AND CD68+IMMUNE CELLS IN PT3-T4 COLORECTAL CANCERS AND RISK OF METACHRONOUS METASTASIS 65
Genetic instability and chromosomal aberrations in colorectal cancer: A review of the current models 65
A novel model to study the in vitro effects of oxidative stress on the DNA mismatch repair system. 65
Activin Induced PI3kinase Leads to a Pro-Migratory, Metastatic Phenotype in Colon Cancer 63
K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers 62
Tertiary intratumor lymphoid tissue in colo-rectal cancer 62
A SIMPLI (Single-cell Identification from MultiPLexed Images) approach for spatially-resolved tissue phenotyping at single-cell resolution 61
IN-VITRO TRANSCRIPTION/TRANSLATION ASSAY FOR THE SCREENING OF HMLH1 AND HMSH2 MUTATIONS IN FAMILIAL COLON-CANCER 61
Colorectal Hereditary Syndromes: Detection, screening and surveillance 61
Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer 61
Adaptive and innate immunity, non clonal player S in colore tal cancer progression 61
EXPRESSION OF THE MESENCHYMAL REGULATOR TWIST1 IN COLORECTAL CANCER CELLS AND STROMA ACCORDING TO MICROSATELLITE AND METASTASIS STATUS, AND ITS ASSOCIATION WITH WORSE OUTCOME 60
COMBINED LOW DENSITIES OF FOXP3+ AND CD3+ TUMOR-INFILTRATING LYMPHOCYTES IDENTIFY STAGE II COLORECTAL CANCER AT VERY HIGH RISK OF PROGRESSION 59
Alternative Splicing of Extra Domain A (EIIIA) of Fibronectin Plays a Tissue-Specific Role in Hematopoietic Homeostasis 59
Journey through crohn’s disease complication: From fistula formation to future therapies 59
High levels of EMT-TFs for the diagnosis of cancer, in particular of colorectal (CRC) and pancreatic (PC) cancer 58
Impairment of colorectal cancer screening during the COVID-19 pandemic 58
COMBINED LOW DENSITIES OF FOXP3þ AND CD3þ TUMOR-INFILTRATING LYMPHOCYTES FOR THE INTRA-STAGE II IDENTIFICATION OF COLORECTAL CANCERS WITH THE HIGHEST RISK OF PROGRESSION 57
Heterogeneity of colorectal cancer progression: Molecular gas and brakes 57
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 57
Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy 57
Proficiency of mismatch repair activity can be retained in spite of tow expression levels of the hMLH-1 gene in the HCT116 colon cancer cell line 56
JC virus and human colon carcinoma: An intriguing and inconclusive association - Reply 56
Multiple analysis for neoplastic evolution in colorectal neoplasia: K-RAS mutations are associated with exophytic neoplastic lesions. 56
Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients 56
FIRST-ROUND SCREENING RESULTS IN SUBJECTS AT RISK OF PANCREATIC CANCER FROM THE AISP (ITALIAN ASSOCIATION FOR THE STUDY OF THE PANCREAS) REGISTRY 55
Frequent coexistence of GAT and GTT mutations of K-ras codon 12 in periampullary tumors. 54
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker 54
Early fractalkine receptor (CX3CR1) switch-on in pancreatic ductal adenocarcinoma is associated with local neural invasion 54
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study 53
CD3+ Lymphocytes and Cd68+ Macrophages at the Invasive Margin of Deeply Invading (pT3-T4) Colorectal Cancer and Risk of Post-Surgical Metastasis: A Longitudinal Study 53
Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease 53
Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells 53
Cancer classification using the Immunoscore: a worldwide task force. 52
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 52
JC virus DNA is present in the mucosa of the human colon and in colorectal cancers 51
Gender differences for Hmlh1 and P16 promoter methylation pattern and for hMLH1 protein loss in patients with MSI sporadic colorectal cancer 51
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 50
Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center 50
Noncathartic CT colonography to screen for colorectal neoplasia in subjects with a family history of colorectal cancer 50
KRAS mutation in lung metastases from colorectal cancer: Prognostic implications 50
The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance 50
Nonmyeloablative allogenic peripheral-blood stem-cell transplantation in pancreatic adenocarcinoma: one case, high expectations 50
Epithelial to mesenchymal transition: A challenging playground for translational research. current models and focus on TWIST1 relevance and gastrointestinal cancers 50
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 49
TWIST1 Positive Cells in the Stroma of Colorectal Cancer: Tumor Cells in Disguise 49
Genetics of colorectal cancer 49
Different spectrum of target gene mutations in hereditary non polyposis colorectal cancers according to hMLH1 and Hmsh2 defects 49
Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers 49
Prognostic significance of tumor-associated macrophages: past, present and future 48
Iron metabolism in cancer progression 48
Likelihood of metastases at diagnosis and disease-specific survival in patients with microsatellite unstable colorectal cancer 48
Tumour-associated macrophages as treatment targets in oncology 48
The human gastrointestinal tract is a reservoir for JC virus infection. 48
MSI CRC accumulated target gene frameshift mutations according to mismatch haploinsufficiency but not to tumor stage 48
Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer 47
Oxidative stress caused by H2O2 downregulates the level of hMSH2 protein. 47
Reduced metastatic potential of microsatellite unstable colorectal cancers with hMLH1 defect, hMSH3 frameshift mutations and ensuing MutS beta defects 47
Juvenile polyposis syndrome: An overview 47
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial 46
Re: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability 46
LOSS OF HMSH3 PROTEIN AS A PROGNOSTIC BIOMARKER FOR MSI COLORECTAL CANCER 46
JC virus and human colon carcinoma: An intriguing and inconclusive association [1] (multiple letters) 46
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes 46
Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-Pair sequence in colon cancer tissues 45
Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon cancer 45
Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma 45
Levofloxacin/Amoxicillin-Based Regimens Versus Quadruple Therapy for Helicobacter pylori Eradication in Second-Line: A Meta-Analysis 44
Fractional allelic loss in non-end-stage cirrhosis: Correlations with hepatocellular carcinoma development during follow-up 44
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer 44
Different spectrum of target gene mutations in hereditary non polyposis colorectal cancers according to hMLH1 and Hmsh2 defects 43
Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases 43
TUMOR INFILTRATING MACROPHAGES AS A POTENTIAL PREDICTIVE BIOMARKER OF RESPONSE TO 5-FU IN PATIENTS WITH MICROSATELLITE-STABLE COLORECTAL CANCER 43
Immune cells: Plastic players along colorectal cancer progression 43
Optimization of Laboratory Diagnostics of Primary Biliary Cholangitis: When Solid-Phase Assays and Immunofluorescence Combine 43
Replication errors at Bat26 and Bat40 loci are not associated to a wild-type K-ras in pancreatic cancers 42
Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle 42
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 42
Genotyping of frameshift mutations in early and metastatic colorectal cancer with microsatellite instability 41
LIKELIHOOD OF METASTASIS AND PATIENTS? SURVIVAL IN SYNCHRONOUS COLORECTAL CANCER DEPEND UPON MS-STATUS 41
EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN HUMAN PANCREATIC CANCER: ASSOCIATION WITH DISEASE DISSEMINATION AND RECURRENCE 41
Gender difference for promoter methylation pattern of hMLH1 and p16 in sporadic MSI colorectal cancer 40
MICROSATELLITE-STATUS PREDICTS METASTASIS AT DIAGNOSIS AND PATIENTS' SURVIVAL IN SYNCHRONOUS COLORECTAL CANCER 40
Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps 40
Comprehensive allelotype study of hepatocellular carcinoma 40
Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 40
Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients 40
Hereditary or sporadic polyposis syndromes 39
Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome 39
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium 38
Totale 5.293
Categoria #
all - tutte 40.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/2021250 2 22 25 3 30 13 67 6 10 21 33 18
2021/2022566 8 2 8 32 17 15 15 43 44 20 22 340
2022/20232.792 409 292 153 150 186 325 34 176 947 19 74 27
2023/2024852 50 104 27 17 120 175 28 53 25 67 58 128
2024/20252.931 31 210 267 147 415 428 102 138 397 344 201 251
Totale 7.593